ARDELYX, INC. Undistributed Earnings, Diluted
ARDELYX, INC. (ARDX) reported Undistributed Earnings, Diluted of $0 for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-12.
Discontinued › Notes › Earnings Per Share
us-gaap:UndistributedEarningsDiluted · last filed 2015-08-12
- ARDELYX, INC. undistributed earnings, diluted for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- ARDELYX, INC. undistributed earnings, diluted for the quarter ending 2014-06-30 was $188.00K.
| Period end | Undistributed Earnings, Diluted 3 month | Undistributed Earnings, Diluted 6 month |
|---|---|---|
| 2015-06-30 | $0.00 10-Q · filed 2015-08-12 | $0.00 10-Q · filed 2015-08-12 |
| 2014-06-30 | $188.00K 10-Q · filed 2015-08-12 | $0.00 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |